Short-Term Ingestion of Medium-Chain Triglycerides Could Enhance Postprandial Consumption of Ingested Fat in Individuals with a Body Mass Index from 25 to Less than 30: A Randomized, Placebo-Controlled, Double-Blind Crossover Study.
Naohisa NosakaShougo TsujinoKazuhiko KatoPublished in: Nutrients (2022)
The elimination of obesity is essential to maintaining good health. Medium-chain triglycerides (MCTs) inhibit fat accumulation. However, studies examining energy expenditure and fat oxidation with continuous ingestion of MCTs show little association with the elimination of obesity. In this study, we conducted a randomized, double-blind crossover clinical trial to investigate the effects of continuous ingestion of MCTs on postprandial energy expenditure and ingested long-chain triglycerides (LCTs) oxidation. A daily 2 g of MCTs were ingested for two weeks by sedentary participants with a body mass index (BMI) from 25 (kg/m 2 ) to less than 30. Ingestion of a meal containing MCTs and isotopic carbon-13-labeled (13C) LCTs increased energy expenditure and consumption of diet-derived LCTs, as determined by postprandial 13C carbon dioxide excretion, compared to canola oil as the placebo control. These results indicate that continuous ingestion of MCTs could enhance postprandial degradation of diet-derived fat and energy expenditure in sedentary, overweight individuals.
Keyphrases
- double blind
- placebo controlled
- physical activity
- body mass index
- weight gain
- clinical trial
- weight loss
- adipose tissue
- phase iii
- blood glucose
- phase ii
- carbon dioxide
- study protocol
- insulin resistance
- fatty acid
- metabolic syndrome
- type diabetes
- high density
- healthcare
- phase ii study
- randomized controlled trial
- public health
- high fat diet induced
- open label
- nitric oxide
- radiation therapy
- climate change
- gestational age
- pet ct
- glycemic control
- blood pressure